AIM: To investigate the roles of lymphocytes in the development of dextran sulfate sodium-induced colitis. METHODS: Using various doses of dextran sulfate sodium (DSS), we induced colitis in wild-type B6 control and Rag-1 knockout (H-2b haplotype) mice, and evaluated the colitis in terms of symptomatic and histologic parameters, such as weight loss, survival, severity of diarrhea, shortage of colon length and histological changes. Symptomatic parameters were checked daily and histological changes were scored. RESULTS: Although development of colitis in Rag-1 knockout mice treated with high dose (5%) of DSS was comparable to that in B6 control mice, colitis progression was much more tolerable in Rag-1 knockout mice compared to than in B6 mice treated with low dose (1.5%) DSS. Symptomatic parameters as well as histopathologic changes were improved in Rag-1 knockout mice. CONCLUSION: These results indicate that the presence of lymphocytes contributes to colitis progression at low dose of DSS stimulation. Lymphocytes may play roles as an aggravating factor in DSS-induced colitis.
AIM: To investigate the roles of lymphocytes in the development of dextran sulfate sodium-induced colitis. METHODS: Using various doses of dextran sulfate sodium (DSS), we induced colitis in wild-type B6 control and Rag-1 knockout (H-2b haplotype) mice, and evaluated the colitis in terms of symptomatic and histologic parameters, such as weight loss, survival, severity of diarrhea, shortage of colon length and histological changes. Symptomatic parameters were checked daily and histological changes were scored. RESULTS: Although development of colitis in Rag-1 knockout mice treated with high dose (5%) of DSS was comparable to that in B6 control mice, colitis progression was much more tolerable in Rag-1 knockout mice compared to than in B6 mice treated with low dose (1.5%) DSS. Symptomatic parameters as well as histopathologic changes were improved in Rag-1 knockout mice. CONCLUSION: These results indicate that the presence of lymphocytes contributes to colitis progression at low dose of DSS stimulation. Lymphocytes may play roles as an aggravating factor in DSS-induced colitis.
Authors: L J Saubermann; P Beck; Y P De Jong; R S Pitman; M S Ryan; H S Kim; M Exley; S Snapper; S P Balk; S J Hagen; O Kanauchi; K Motoki; T Sakai; C Terhorst; Y Koezuka; D K Podolsky; R S Blumberg Journal: Gastroenterology Date: 2000-07 Impact factor: 22.682
Authors: L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees Journal: Clin Exp Immunol Date: 1998-12 Impact factor: 4.330
Authors: Claire B Larmonier; Kareem W Shehab; Daniel Laubitz; Deepa R Jamwal; Fayez K Ghishan; Pawel R Kiela Journal: J Biol Chem Date: 2016-02-24 Impact factor: 5.157
Authors: P L Beck; E Ihara; S A Hirota; J A MacDonald; D Meng; N N Nanthakumar; D K Podolsky; R J Xavier Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-03-18 Impact factor: 4.052
Authors: Beate C Sydora; Eric J Albert; Rae R Foshaug; Jason S G Doyle; Thomas A Churchill; Richard N Fedorak Journal: Dig Dis Sci Date: 2011-09-01 Impact factor: 3.199
Authors: Colm B Collins; Derek Strassheim; Carol M Aherne; Alyson R Yeckes; Paul Jedlicka; Edwin F de Zoeten Journal: Inflamm Bowel Dis Date: 2014-04 Impact factor: 5.325
Authors: Aubrey L Frantz; Maria E C Bruno; Eric W Rogier; Halide Tuna; Donald A Cohen; Subbarao Bondada; R Lakshman Chelvarajan; J Anthony Brandon; C Darrell Jennings; Charlotte S Kaetzel Journal: Inflamm Bowel Dis Date: 2012-02-22 Impact factor: 5.325
Authors: Kshipra Singh; Lori A Coburn; Daniel P Barry; Mohammad Asim; Brooks P Scull; Margaret M Allaman; Nuruddeen D Lewis; M Kay Washington; Michael J Rosen; Christopher S Williams; Rupesh Chaturvedi; Keith T Wilson Journal: Am J Physiol Gastrointest Liver Physiol Date: 2013-05-23 Impact factor: 4.052
Authors: Lisa C Osborne; Karen L Joyce; Theresa Alenghat; Gregory F Sonnenberg; Paul R Giacomin; Yurong Du; Kirk S Bergstrom; Bruce A Vallance; Meera G Nair Journal: J Immunol Date: 2013-01-25 Impact factor: 5.422